相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High rate of sustained virological response with direct-acting antivirals in haemophiliacs with HCV infection: A multicenter study
Maria Elisa Mancuso et al.
LIVER INTERNATIONAL (2020)
EASL Recommendations on Treatment of Hepatitis C 2018
JOURNAL OF HEPATOLOGY (2018)
Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection
Ulrich Spengler
PHARMACOLOGY & THERAPEUTICS (2018)
Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naive or Treatment-Experienced
Hyun Woong Lee et al.
GUT AND LIVER (2017)
Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy
Goki Suda et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada
Naveed Z. Janjua et al.
JOURNAL OF HEPATOLOGY (2017)
Direct-acting antivirals: the endgame for hepatitis C?
Roberta D'Ambrosio et al.
CURRENT OPINION IN VIROLOGY (2017)
Medical co-morbidities of patients with haemophilia: pain, obesity and hepatitis C
M. L. Witkop et al.
HAEMOPHILIA (2016)
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Fabio Conti et al.
JOURNAL OF HEPATOLOGY (2016)
Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure
Jun Itakura et al.
PLoS One (2016)
Treatment of hepatitis C in difficult-to-treat patients
Peter Ferenci
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea
Suh Yoon Yang et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2015)
Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection
Hiromitsu Kumada et al.
HEPATOLOGY (2014)
Global epidemiology and genotype distribution of the hepatitis C virus infection
Erin Gower et al.
JOURNAL OF HEPATOLOGY (2014)
Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders
Dietje Elisabeth Fransen van de Putte et al.
JOURNAL OF HEPATOLOGY (2014)
Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study
Eiichi Ogawa et al.
JOURNAL OF HEPATOLOGY (2013)
Long-term clearance of hepatitis C virus following interferon-2b or peginterferon-2b, alone or in combination with ribavirin
M. P. Manns et al.
JOURNAL OF VIRAL HEPATITIS (2013)
A nationwide seroepidemiology of hepatitis C virus infection in South Korea
Do Young Kim et al.
LIVER INTERNATIONAL (2013)
Effect of Aging on Risk for Hepatocellular Carcinoma in Chronic Hepatitis C Virus Infection
Yasuhiro Asahina et al.
HEPATOLOGY (2010)
Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels
Takashi Kumada et al.
JOURNAL OF HEPATOLOGY (2009)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
M Pérez-Olmeda et al.
AIDS (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985
TT Yee et al.
GUT (2000)
分享论文
